PepGen (PEPG) Stock Forecast, Price Target & Predictions
PEPG Stock Forecast
PepGen stock forecast is as follows: an average price target of $29.50 (represents a 570.45% upside from PEPG’s last price of $4.40) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
PEPG Price Target
PEPG Analyst Ratings
Buy
PepGen Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Dec 21, 2022 | - | H.C. Wainwright | $26.00 | $14.51 | 79.19% | 490.91% |
Nov 10, 2022 | - | Leerink Partners | $33.00 | $12.50 | 164.00% | 650.00% |
10
PepGen Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $4.40 | $4.40 | $4.40 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Nov 18, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
Nov 10, 2022 | SVB Leerink | Outperform | Outperform | Hold |
May 31, 2022 | Bank of America Securities | - | Buy | Initialise |
10
PepGen Financial Forecast
PepGen Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - |
# Analysts | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - |
Forecast
PepGen EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - |
Forecast
PepGen Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - | - |
Avg Forecast | $-25.25M | $-24.44M | $-23.78M | $-22.97M | $-26.52M | $-28.30M | $-23.44M |
High Forecast | $-25.25M | $-24.44M | $-23.78M | $-21.03M | $-20.30M | $-28.30M | $-23.44M |
Low Forecast | $-25.25M | $-24.44M | $-23.78M | $-24.59M | $-34.38M | $-28.30M | $-23.44M |
Surprise % | - | - | - | - | - | - | - |
Forecast
PepGen SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - |
SG&A | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - |
Forecast
PepGen EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - |
Avg Forecast | $-0.78 | $-0.75 | $-0.73 | $-0.70 | $-0.81 | $-0.87 | $-0.72 |
High Forecast | $-0.78 | $-0.75 | $-0.73 | $-0.65 | $-0.62 | $-0.87 | $-0.72 |
Low Forecast | $-0.78 | $-0.75 | $-0.73 | $-0.75 | $-1.06 | $-0.87 | $-0.72 |
Surprise % | - | - | - | - | - | - | - |
Forecast
PepGen Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
IPSC | Century Therapeutics | $1.26 | $15.00 | 1090.48% | Buy |
PMVP | PMV Pharmaceuticals | $1.57 | $18.00 | 1046.50% | Buy |
ANTX | AN2 Therapeutics | $1.30 | $8.75 | 573.08% | Buy |
PEPG | PepGen | $4.40 | $29.50 | 570.45% | Buy |
MOLN | Molecular Partners | $5.20 | $29.00 | 457.69% | Buy |
CMPX | Compass Therapeutics | $1.37 | $5.00 | 264.96% | Buy |
VIGL | Vigil Neuroscience | $3.05 | $11.00 | 260.66% | Buy |
CCCC | C4 Therapeutics | $4.05 | $13.50 | 233.33% | Buy |
PRTC | PureTech Health | $21.70 | $57.00 | 162.67% | Buy |
ELYM | Eliem Therapeutics | $5.11 | $13.00 | 154.40% | Buy |
CGEM | Cullinan Oncology | $12.58 | $31.50 | 150.40% | Buy |
MLYS | Mineralys Therapeutics | $12.60 | $30.00 | 138.10% | Buy |
TYRA | Tyra Biosciences | $15.87 | $31.75 | 100.06% | Buy |
PHVS | Pharvaris | $20.50 | $39.67 | 93.51% | Buy |
EWTX | Edgewise Therapeutics | $31.95 | $45.00 | 40.85% | Buy |
TRDA | Entrada Therapeutics | $17.93 | $20.00 | 11.54% | Buy |